Bessemer Group Inc. increased its position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 21.3% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 349,342 shares of the company’s stock after purchasing an additional 61,317 shares during the period. Bessemer Group Inc. owned 0.41% of HealthEquity worth $33,108,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC lifted its stake in HealthEquity by 2.9% in the second quarter. Nisa Investment Advisors LLC now owns 3,787 shares of the company’s stock valued at $397,000 after buying an additional 108 shares during the last quarter. Advisors Asset Management Inc. raised its position in HealthEquity by 4.7% in the 2nd quarter. Advisors Asset Management Inc. now owns 2,437 shares of the company’s stock valued at $255,000 after purchasing an additional 110 shares during the last quarter. Coldstream Capital Management Inc. boosted its stake in HealthEquity by 7.3% during the 2nd quarter. Coldstream Capital Management Inc. now owns 2,027 shares of the company’s stock worth $212,000 after purchasing an additional 138 shares during the period. Farther Finance Advisors LLC boosted its stake in HealthEquity by 59.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock worth $37,000 after purchasing an additional 146 shares during the period. Finally, Elevation Point Wealth Partners LLC grew its position in HealthEquity by 4.5% during the 2nd quarter. Elevation Point Wealth Partners LLC now owns 3,562 shares of the company’s stock worth $373,000 after purchasing an additional 152 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.
Wall Street Analyst Weigh In
HQY has been the subject of a number of research reports. JPMorgan Chase & Co. upped their target price on shares of HealthEquity from $126.00 to $129.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. Citigroup restated an “outperform” rating on shares of HealthEquity in a research report on Thursday, December 4th. JMP Securities set a $122.00 price objective on HealthEquity in a research note on Thursday, December 4th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $120.00 price objective on shares of HealthEquity in a research report on Friday, December 5th. Finally, Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a report on Monday, January 19th. Two research analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and a consensus price target of $119.60.
Insiders Place Their Bets
In other HealthEquity news, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the transaction, the executive vice president directly owned 45,742 shares in the company, valued at approximately $4,366,073.90. This represents a 19.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Delano Ladd sold 1,500 shares of the stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the transaction, the executive vice president directly owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 13,959 shares of company stock worth $1,344,957. Corporate insiders own 1.50% of the company’s stock.
HealthEquity Price Performance
Shares of HQY opened at $79.22 on Friday. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46. The stock’s 50 day moving average is $91.06 and its two-hundred day moving average is $93.11. HealthEquity, Inc. has a twelve month low of $74.07 and a twelve month high of $116.65. The firm has a market capitalization of $6.77 billion, a PE ratio of 36.34, a P/E/G ratio of 1.01 and a beta of 0.24.
HealthEquity (NASDAQ:HQY – Get Free Report) last posted its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The business had revenue of $322.16 million during the quarter, compared to analysts’ expectations of $320.92 million. During the same period last year, the firm earned $0.78 EPS. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Research analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current year.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Featured Articles
- Five stocks we like better than HealthEquity
- Your Bank Account Is No Longer Safe
- When to buy gold (mathematically)
- What a Former CIA Agent Knows About the Coming Collapse
- Nervous about the stock market? Read this
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
